CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/KRAS and IGF2BP2/Myc axes.
Jie LiXinya GaoZhanqiang ZhangYuanhui LaiXunxun LinBo LinMaoguang MaXiaoli LiangXixi LiWeiming LvYing LinNu ZhangPublished in: Molecular cancer (2021)
Our data suggested that overexpressed circCD44 promotes TNBC progression. CircCD44 is potentially a novel diagnostic and therapeutic marker for TNBC patients.